Daniel S. Peeper
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?
Journal: Journal for immunotherapy of cancer
Published: November 05, 2025
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing.
Journal: Cell death discovery
Published: May 23, 2025
Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.
Journal: Cancer research
Published: April 28, 2025
Resistance to BRAF inhibitors drives melanoma sensitivity to Chk1 inhibition.
Journal: Pharmacological research
Published: March 08, 2025
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.
Journal: Journal for immunotherapy of cancer
Published: August 09, 2024
Rational combination of cancer therapies with PD1 axis blockade.
Journal: Nature reviews. Cancer
Published: July 30, 2024
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer.
Journal: Nucleic acids research
Published: July 29, 2024
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors.
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors.
Journal: Cell death & disease
Published: April 30, 2024
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.
Journal: Nature genetics
Published: November 17, 2023
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.
Journal: Nature
Published: August 02, 2023
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.
Journal: Cancer cell
Published: July 07, 2023
Phosphoprotein dynamics of interacting T cells and tumor cells by HySic.
Journal: Cell reports
Published: May 30, 2023
Last Updated: 09/26/2026